UK Companies House feature
BAP PHARMA LIMITED
Profile
- Company number
- 07406019
- Status
- Active
- Incorporation
- 2010-10-13
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Brian Paul Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “Launch of two new divisions: Secondary Packaging & Labelling and Medicines Access.”
- “Opening of a state-of-the-art facility in New Jersey, USA.”
- “Achievement of Silver EcoVadis rating and ISO14001 Certification for Environmental Management System in 2024.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PARKAR, Bashir Ahmed, Dr | Director | 2010-10-13 | Jun 1959 | British |
| PARKAR, Nafisa | Director | 2010-10-13 | Aug 1962 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MAGNA SECRETARIES LIMITED | Corporate Secretary | 2010-10-13 | 2011-10-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bap Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-06-09 | Active |
| Bappharma Group Limited | Corporate entity | ownership-of-shares-75-to-100-percent-as-firm, voting-rights-75-to-100-percent-as-firm, right-to-appoint-and-remove-directors-as-firm | 2016-07-01 | Ceased 2022-06-09 |
Filing timeline
Last 20 of 52 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-20 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-08-26 | AA | accounts | accounts with accounts type full |
| 2024-10-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-08-21 | AA | accounts | accounts with accounts type full |
| 2023-10-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-09-27 | AA | accounts | accounts with accounts type full |
| 2022-10-17 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-09-20 | AA | accounts | accounts with accounts type full |
| 2022-06-30 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2022-06-30 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2022-04-06 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2021-10-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-08 | AD01 | address | change registered office address company with date old address new address |
| 2021-09-21 | AA | accounts | accounts with accounts type full |
| 2020-10-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-08-20 | AA | accounts | accounts with accounts type full |
| 2019-10-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-08-23 | AA | accounts | accounts with accounts type full |
| 2018-10-22 | CS01 | confirmation-statement | confirmation statement with updates |
| 2018-10-22 | PSC05 | persons-with-significant-control | change to a person with significant control |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.